General Information of Drug (ID: DM1TG3C)

Drug Name
Oxamflatin Drug Info
Synonyms
NSC729360; CHEBI:258842; I14-11718; NCGC00165855-01; (2E)-5-(3-(phenylsulfonylamino)phenyl)pent-2-ene-4-ynohydroxamic acid; (2E)-5-[3-(Phenylsulfonylamino)phenyl]pent-2-en-4-ynohydroxamic Acid; (E)-5-[3-(benzenesulfonamido)phenyl]-N-hydroxypent-2-en-4-ynamide; 151720-43-3
Therapeutic ClassAnticancer Agents
Cross-matching ID
PubChem CID
5353852
ChEBI ID
CHEMBL93779
CAS Number
CAS 151720-43-3
TTD Drug ID
D03YVR

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Synaptic vesicle cycle 2.05 1.05e-2 63/78 (80.77%) STX1A;ATP6V1D;ATP6V0E2;...
Ribosome 1.92 1.58e-2 113/158 (71.52%) RPL36;FAU;RPS4Y1;...
ECM-receptor interaction -2.03 9.43e-3 80/88 (90.91%) COL9A3;ITGB8;ITGB7;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Fibroblast
Nasopharyngeal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
FIBRNPC CVCL_UK07 Homo sapiens 10uM 6H, 24H